Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Oliceridine versus sufentanil for postoperative PCIA in elderly patients after laparoscopic radical gastrointestinal tumor surgery
ChiCTR2400090780Phase 4Recruiting
- Sponsor
- Tangdu Hospital
- Start
- Oct 2024
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Small Molecules
- Countries
- 1
01
Overview
Phase 4 trial of oliceridine and sufentanil in acute pain (2 arms), sponsored by Tangdu Hospital. Primary endpoint: Area under the curve of pain score at rest over 0-48 hours after surgery. Started Oct 2024; status: recruiting.
02
Drugs
oliceridinesufentanil
03
Conditions
acute pain
Beyond the preview
Go deeper on ChiCTR2400090780.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2400090780.